Familial Limb Girdle Myasthenia Syndrome via the DOK7 Gene
Summary and Pricing
Test Method
Sequencing and CNV Detection via NextGen Sequencing using PG-Select Capture ProbesTest Code | Test Copy Genes | Test CPT Code | Gene CPT Codes Copy CPT Code | Base Price | |
---|---|---|---|---|---|
7629 | DOK7 | 81479 | 81479,81479 | $990 | Order Options and Pricing |
Pricing Comments
Testing run on PG-select capture probes includes CNV analysis for the gene(s) on the panel but does not permit the optional add on of exome-wide CNV analysis. Any of the NGS platforms allow reflex to other clinically relevant genes, up to whole exome or whole genome sequencing depending upon the base platform selected for the initial test.
An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.
This test is also offered via a custom panel (click here) on our exome or genome backbone which permits the optional add on of exome-wide CNV or genome-wide SV analysis.
Turnaround Time
3 weeks on average for standard orders or 2 weeks on average for STAT orders.
Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.
Targeted Testing
For ordering sequencing of targeted known variants, go to our Targeted Variants page.
Clinical Features and Genetics
Clinical Features
Congenital myasthenic syndromes (CMS) are disorders of the neuromuscular junction resulting from defects in presynaptic, synaptic, or post-synaptic proteins. The protein encoded by DOK7 is essential for neuromuscular synaptogenesis due to its role in inducing autophosphorylation of the skeletal muscle receptor-like tyrosine kinase (MuSK), a key protein involved in postsynaptic differentiation (Okada et al. Science 312:1802-1805, 2006). Variants in DOK7 result in small neuromuscular junctions but normal acetylcholine receptor and acetylcholinesterase function (Beeson et al. Science 313:1975-1978, 2006). Electron microscopy studies of patients with DOK7 variants shows destruction and remodeling of end plates at neuromuscular junctions (Selcen et al. Ann Neurol 64:71-87, 2008). Clinically, a limb girdle pattern of muscle involvement makes DOK7-related CMS unique from other forms of CMS. Age at onset typically ranges from birth to five years of age (Selcen et al. 2008) with onset in a minority of patients occurring beyond age five years (Beeson et al. 2006). The latter study found that the most common clinical presentation was difficulty in walking after initially achieving normal walking milestones. In a cohort of sixteen DOK7 positive patients characterized by Selcen et al. (2008), disease severity and rate of progression was variable; some patients exhibited mild static weakness limited to limb girdle muscles, while others had severe generalized disease with muscle atrophy. Ten of the sixteen patients had intermittent worsening of symptoms lasting from days to weeks. All patients reported fatigue on exertion and proximal muscle weakness. Other common features among the sixteen patients included ptosis (14/16), facial weakness (13/16), bulbar symptoms (11/16), and respiratory difficulties (13/16).
Genetics
Familial limb girdle myasthenic syndrome due to DOK7 gene variants (OMIM 254300) is inherited as an autosomal recessive disorder. In a cohort of 21 patients, Beeson et al. (2006) found 16 to have the same exon 7 variant (c.1124_1127dupTGCC). Fourteen of 16 patients reported by Selcen et al. (2008) had a least one allele with the c.1124_1127dupTGCC variant, and four were found to have heterozygous gross alterations (intron inclusion or exon skipping) undetectable in genomic DNA.
Clinical Sensitivity - Sequencing with CNV PG-Select
DOK7, AGRN, and GFPT1 variants are the only known cause of familial limb girdle myasthenic syndrome. Clinical sensitivity should be high for patients meeting rigorous clinical, histopathological, and electrophysiological criteria.
Testing Strategy
This test provides full coverage of all coding exons of the DOK7 gene, plus ~10 bases of flanking noncoding DNA. We define full coverage as >20X NGS reads or Sanger sequencing.
Indications for Test
Individuals with a limb girdle pattern of muscle weakness along with other typical CMS muscle involvement. This test may also be considered for the reproductive partners of individuals who carry pathogenic variants in DOK7.
Individuals with a limb girdle pattern of muscle weakness along with other typical CMS muscle involvement. This test may also be considered for the reproductive partners of individuals who carry pathogenic variants in DOK7.
Gene
Official Gene Symbol | OMIM ID |
---|---|
DOK7 | 610285 |
Inheritance | Abbreviation |
---|---|
Autosomal Dominant | AD |
Autosomal Recessive | AR |
X-Linked | XL |
Mitochondrial | MT |
Diseases
Name | Inheritance | OMIM ID |
---|---|---|
Fetal Akinesia Deformation Sequence | AR | 208150 |
Myasthenia, Limb-Girdle, Familial | AR | 254300 |
Related Test
Name |
---|
Fetal Akinesia Deformation Sequence (FADS)/Lethal Multiple Pterygium Syndrome Panel |
Citations
- Beeson, D., et.al. (2006). "Dok-7 mutations underlie a neuromuscular junction synaptopathy." Science 313(5795): 1975-8. PubMed ID: 16917026
- Okada, K., et.al. (2006). "The muscle protein Dok-7 is essential for neuromuscular synaptogenesis." Science 312(5781): 1802-5. PubMed ID: 16794080
- Selcen, D., et.al. (2008). "Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients." Ann Neurol 64(1): 71-87. PubMed ID: 18626973
Ordering/Specimens
Ordering Options
We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.
myPrevent - Online Ordering
- The test can be added to your online orders in the Summary and Pricing section.
- Once the test has been added log in to myPrevent to fill out an online requisition form.
- PGnome sequencing panels can be ordered via the myPrevent portal only at this time.
Requisition Form
- A completed requisition form must accompany all specimens.
- Billing information along with specimen and shipping instructions are within the requisition form.
- All testing must be ordered by a qualified healthcare provider.
For Requisition Forms, visit our Forms page
If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.
Specimen Types
ORDER OPTIONS
View Ordering Instructions1) Select Test Type
2) Select Additional Test Options
No Additional Test Options are available for this test.